Overview

A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer

Status:
Unknown status

Trial end date:
2013-04-01

Target enrollment:

Participant gender:

Summary

Through clinical practice, to explore if the application of Fluorouracil implant could effectively delay the local tumor recurrence and improvement the postoperative survival time in patients with gallbladder cancer and bile duct cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Simcere Pharmaceutical Co., Ltd

Collaborator:

Eastern Hepatobiliary Surgery Hospital

Treatments:

Fluorouracil